Dissolving microneedles for transdermal drug delivery.
By Jeong Woo Lee, Jung-Hwan Park, Mark R. Prausnitz. Biomaterials, 2008
906 citations recorded by the source corpus.
Subfields: Dermatology, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/c3b4e7a9365520581b031ab30a431699d8f0543c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Dermatology
- K. van der Maaden
- W. Jiskoot
- J. Bouwstra
- Robert Langer
- Mark R. Prausnitz
- Jung-Hwan Park
- Yeu‐Chun Kim
In Pharmaceutical Science
- K. van der Maaden
- W. Jiskoot
- J. Bouwstra
- Robert Langer
- Jung-Hwan Park
- Mark R. Prausnitz
- Yeu‐Chun Kim
- R. Donnelly
Citations in the corpus
- Transdermal drug delivery (2008, methodology): “We have also made microneedles of water-soluble polymers that encapsulate various compounds within the needle matri”
- Microneedles for drug and vaccine delivery (2012, background): “rences (a) [112], (b) [111], (c) [126], (d) [125], (e) [139], (f) [50], (g) [118] and (h) [129].”
- Microneedle technologies for (trans)dermal drug and vaccine delivery. (2012, methodology): “Microneedles have been coated with a broad range of drugs, such as hydrophilic and hydrophobic low-molecular-weight drugs, DNA, RNA, proteins, peptides, inactivated pathogens, and particles [10, 27, 44, 94, 95, 100, 101].”
- Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin. (2017, background): “Casting solvent onto molds, where the solvent typically is water, is often used to make polymer microneedles (53, 66, 81).”